Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation Treatment.

MLA

Cogen, Jonathan D., et al. “Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation Treatment.” Annals of the American Thoracic Society, vol. 18, no. 2, Feb. 2021, pp. 266–72. EBSCOhost, https://doi.org/10.1513/AnnalsATS.202002-176OC.

APA

Cogen, J. D., Faino, A. V., Onchiri, F., Gibson, R. L., Hoffman, L. R., Kronman, M. P., Rosenfeld, M., & Nichols, D. P. (2021). Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation Treatment. Annals of the American Thoracic Society, 18(2), 266–272. https://doi.org/10.1513/AnnalsATS.202002-176OC

Chicago

Cogen, Jonathan D., Anna V. Faino, Frankline Onchiri, Ronald L. Gibson, Lucas R. Hoffman, Matthew P. Kronman, Margaret Rosenfeld, and David P. Nichols. 2021. “Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation Treatment.” Annals of the American Thoracic Society 18 (2): 266–72. doi:10.1513/AnnalsATS.202002-176OC.